The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.
about
Molecular analysis of thymopentin binding to HLA-DR moleculesTau protein binds to microtubules through a flexible array of distributed weak sitesPatients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 moleculesAnalysis of murine major histocompatibility complex class II-restricted T-cell responses to the flavivirus Kunjin by using vaccinia virus expressionStructural Basis of Cytochrome c Presentation by IE kSecondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition.NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequencePeripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d IFlanking p10 contribution and sequence bias in matrix based epitope prediction: revisiting the assumption of independent binding pocketsT cell receptor gene in synovial tissues of rheumatoid arthritis.Rous-Whipple Award Lecture. Chemical features of peptide selection by the class II histocompatibility molecules.Lymphocyte responses to DR1/4 restricted peptides in rheumatoid arthritis.Identification of residues necessary for clonally specific recognition of a cytotoxic T cell determinant.HLA class II allelic variation and susceptibility to pemphigus vulgarisRole for intracellular proteases in the processing and transport of class II HLA antigens.Kinetics of gamma interferon binding and induction of major histocompatibility complex class II mRNA in Leishmania-infected macrophages.Refolding and reassembly of separate alpha and beta chains of class II molecules of the major histocompatibility complex leads to increased peptide-binding capacity.Interaction of an immunodominant epitope with Ia molecules in T-cell activation.The invariant chain forms complexes with class II major histocompatibility complex molecules and antigenic peptides "in vivo".Class I major histocompatibility complex-restricted cytolytic T lymphocytes recognize a limited number of sites on the influenza hemagglutinin.Nucleotide substitution at major histocompatibility complex class II loci: evidence for overdominant selection.Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes.Vaccine T-cell epitope selection by a peptide competition assayMajor histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells.Relative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses.Properties of HLA class II molecules divergently associated with Goodpasture's disease.Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding.Defects in antigen presentation of mutant influenza haemagglutinins are reversed by mutations in the MHC class II moleculeA subdominant CD8(+) cytotoxic T lymphocyte (CTL) epitope from the Plasmodium yoelii circumsporozoite protein induces CTLs that eliminate infected hepatocytes from culture.Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen.Expression of interleukin 2 receptors by monocytes from patients with acquired immunodeficiency syndrome and induction of monocyte interleukin 2 receptors by human immunodeficiency virus in vitro.Inhibition of allorecognition by an H-2Kb-derived peptide is evidence for a T-cell binding region on a major histocompatibility complex molecule.Interaction of Staphylococcus aureus toxin "superantigens" with human T cellsPrevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins.Peripheral tolerance to allogeneic class II histocompatibility antigens expressed in transgenic mice: evidence against a clonal-deletion mechanismPredominant role of amino-terminal sequences in dictating efficiency of class II major histocompatibility complex alpha beta dimer expression.Species-specific inhibition of fertilization by a peptide derived from the sperm protein bindinBinding interactions between peptides and proteins of the class II major histocompatibility complex.Molecular characterization of human Ro/SS-A antigen. Amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity of a corresponding synthetic peptideAutoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene
P2860
Q21092228-91940F4F-B4D0-40C7-B327-ADB7DD6B29A4Q24323891-AEB9C744-26CD-49FA-89CC-AE49EB5B2AC4Q27478466-85DA64B3-4B1A-4966-AB27-2C704D24ED9CQ27486237-8C05CB68-68A9-4533-87FF-B2DC8A38574AQ27638866-08360431-D392-4479-A7F5-842EFF0A20E4Q27653882-3F7A7D0E-38C4-486D-B349-2A9CC7556F3EQ28469279-0FCE5096-327B-49F8-A30A-E315AE8337EDQ30454050-4F8CA480-D096-4853-B1D5-8CB807EFC688Q33377255-81091513-076B-46D8-88C1-5AB7EDF63353Q33536193-11C2B18C-7EE1-4F2D-B940-155929D5E483Q33541540-4F01CFFC-4192-49E4-8A0A-C5069953309AQ33566179-72C4E473-BCEE-45A3-921E-275B42256609Q33572540-FEBCA106-69B3-4D7A-94ED-C79850540850Q33574546-34C37E4B-B914-45CC-8DD6-27287A4FDA0FQ33578498-6C27CE3B-2A70-4D1A-90A0-60D4CB575CB5Q33581481-414033C9-D366-4A04-BA98-CBB2FEF8403AQ33606693-A4E485D0-9497-42BB-8C33-8E2B9245831DQ33632555-94FED3D7-FFD3-4942-8B50-AEABC2324636Q33796819-F8CC087C-C12F-4EA1-9892-80BD4B319277Q33829395-504F9F8A-7D25-48B0-8785-7DC91C61FC13Q33835136-2A96A15D-71E8-4D84-B22F-03983ABB5250Q33835879-D8359EE5-031F-402B-A2E2-1F2FE2587D5AQ33841060-95AAF169-2871-4E87-A501-DAD5EE252FE4Q33850600-BF8CD629-99B9-4629-8C78-8D150D918593Q33863544-778479CF-1D32-4D3A-B2D3-B6564AAA8971Q33911738-2DD2622B-75D1-4CF6-B96F-7A5253FC9B7AQ33920167-8B7AA460-149B-444A-AD37-49E5DB3AA704Q33923248-C09FAB92-B823-454E-946C-39C06EF861D9Q34004723-3EFCCEE0-DE24-4A84-844D-0080D8F6D55EQ34225571-D7308841-378F-4D39-A3D1-F4D550487100Q34240496-FF7064AF-5EFA-4914-8407-E234B5C6F911Q34317261-EC0E30DC-E315-4E27-B754-4CE230D46407Q34319909-96714867-89B2-4EE8-9A2E-DA79B3AEA8E3Q34323651-136BD7BD-5767-4C74-9919-3032B17A24DEQ34326458-72307D72-1653-4B23-BB92-09066857DBEFQ34366355-73FA42AC-2423-4390-A252-4E9B8BBEDC8BQ34436425-A7431BE4-7E23-4B6A-941F-54039E2EACB1Q34540061-422C02A0-FDE1-4B43-934B-8ADB2BE09657Q34556697-6025B506-EAB5-41D3-BE99-CD1097217D5CQ34567815-E5BBB938-8494-46B9-A175-7D0D44C736C5
P2860
The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
The relation between major his ...... to bind immunogenic peptides.
@en
The relation between major histocompatibility complex
@nl
type
label
The relation between major his ...... to bind immunogenic peptides.
@en
The relation between major histocompatibility complex
@nl
prefLabel
The relation between major his ...... to bind immunogenic peptides.
@en
The relation between major histocompatibility complex
@nl
P2093
P356
P1433
P1476
The relation between major his ...... to bind immunogenic peptides.
@en
P2093
P304
P356
10.1126/SCIENCE.2435001
P407
P577
1987-03-01T00:00:00Z